HomeCompareZBH vs GS

ZBH vs GS: Dividend Comparison 2026

ZBH yields 1.08% · GS yields 1.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GS wins by $53.75M in total portfolio value
10 years
ZBH
ZBH
● Live price
1.08%
Share price
$88.62
Annual div
$0.96
5Y div CAGR
0.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.2K
Annual income
$118.64
Full ZBH calculator →
GS
GS
● Live price
1.92%
Share price
$807.60
Annual div
$15.50
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$53.77M
Annual income
$48,880,568.44
Full GS calculator →

Portfolio growth — ZBH vs GS

📍 GS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZBHGS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZBH + GS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZBH pays
GS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZBH
Annual income on $10K today (after 15% tax)
$92.08/yr
After 10yr DRIP, annual income (after tax)
$100.84/yr
GS
Annual income on $10K today (after 15% tax)
$163.14/yr
After 10yr DRIP, annual income (after tax)
$41,548,483.17/yr
At 15% tax rate, GS beats the other by $41,548,382.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZBH + GS for your $10,000?

ZBH: 50%GS: 50%
100% GS50/50100% ZBH
Portfolio after 10yr
$26.90M
Annual income
$24,440,343.54/yr
Blended yield
90.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GS right now

ZBH
Analyst Ratings
17
Buy
21
Hold
3
Sell
Consensus: Hold
Price Target
$105.60
+19.2% upside vs current
Range: $89.00 — $122.00
Altman Z
1.7
Piotroski
7/9
GS
Analyst Ratings
22
Buy
30
Hold
3
Sell
Consensus: Hold
Price Target
$915.15
+13.3% upside vs current
Range: $604.00 — $1,100.00
Altman Z
0.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZBH buys
0
GS buys
0
No recent congressional trades found for ZBH or GS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZBHGS
Forward yield1.08%1.92%
Annual dividend / share$0.96$15.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.2%100%
Portfolio after 10y$21.2K$53.77M
Annual income after 10y$118.64$48,880,568.44
Total dividends collected$1.1K$53.37M
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldHold
Analyst price target$105.60$915.15

Year-by-year: ZBH vs GS ($10,000, DRIP)

YearZBH PortfolioZBH Income/yrGS PortfolioGS Income/yrGap
1← crossover$10,809$108.54$11,084$383.85$275.00GS
2$11,675$109.86$12,655$795.25$980.00GS
3$12,603$111.13$15,238$1,697.15$2.6KGS
4$13,598$112.34$20,124$3,819.72$6.5KGS
5$14,663$113.51$30,962$9,429.13$16.3KGS
6$15,804$114.62$60,246$27,116.14$44.4KGS
7$17,026$115.69$163,084$98,620.80$146.1KGS
8$18,335$116.71$673,498$498,998.66$655.2KGS
9$19,736$117.70$4,572,513$3,851,869.45$4.55MGS
10$21,236$118.64$53,773,157$48,880,568.44$53.75MGS

ZBH vs GS: Complete Analysis 2026

ZBHHealthcare

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Full ZBH Calculator →

GSFinancials

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through four segments: Investment Banking, Global Markets, Asset Management, and Consumer & Wealth Management. The company's Investment Banking segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and middle-market lending, relationship lending, and acquisition financing, as well as transaction banking services. This segment also offers underwriting services, such as equity underwriting for common and preferred stock and convertible and exchangeable securities; and debt underwriting for various types of debt instruments, including investment-grade and high-yield debt, bank and bridge loans, and emerging-and growth-market debt, as well as originates structured securities. Its Global Markets segment is involved in client execution activities for cash and derivative instruments; credit and interest rate products; and provision of equity intermediation and equity financing, clearing, settlement, and custody services, as well as mortgages, currencies, commodities, and equities related products. The company's Asset Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, as well as invests in corporate, real estate, and infrastructure entities. Its Consumer & Wealth Management segment offers wealth advisory and banking services, including financial planning, investment management, deposit taking, and lending; private banking; and unsecured loans, as well as accepts saving and time deposits. The company was founded in 1869 and is headquartered in New York, New York.

Full GS Calculator →
📬

Get this ZBH vs GS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZBH vs SCHDZBH vs JEPIZBH vs OZBH vs KOZBH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.